DAFNA Capital Management

DAFNA Capital Management as of March 31, 2024

Portfolio Holdings for DAFNA Capital Management

DAFNA Capital Management holds 72 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p Biotech Etf Etf (XBI) 9.3 $41M 431k 94.89
Stereotaxis Com New (STXS) 8.1 $36M 14M 2.61
Cytokinetics Com New (CYTK) 6.4 $28M 398k 70.11
Ideaya Biosciences (IDYA) 4.5 $20M 446k 43.88
Merus N V (MRUS) 3.9 $17M 379k 45.03
Revolution Medicines (RVMD) 3.8 $17M 512k 32.23
Viking Therapeutics (VKTX) 3.6 $16M 194k 82.00
Syndax Pharmaceuticals (SNDX) 3.6 $16M 660k 23.80
Ishares Nasdaq Biotech Indx Etf (IBB) 3.2 $14M 103k 137.22
Ascendis Pharma A/s Sponsored Adr (ASND) 3.2 $14M 93k 151.17
Xenon Pharmaceuticals (XENE) 2.7 $12M 274k 43.05
Day One Biopharmaceuticals I (DAWN) 2.5 $11M 667k 16.52
Blueprint Medicines (BPMC) 2.3 $10M 107k 94.86
Neurocrine Biosciences (NBIX) 2.2 $9.9M 72k 137.92
Kalvista Pharmaceuticals (KALV) 2.2 $9.6M 807k 11.86
Tandem Diabetes Care Com New (TNDM) 2.1 $9.1M 258k 35.41
Dex (DXCM) 2.1 $9.1M 66k 138.70
Kura Oncology (KURA) 2.0 $8.8M 413k 21.33
AtriCure (ATRC) 1.9 $8.2M 271k 30.42
Morphic Hldg (MORF) 1.9 $8.2M 232k 35.20
Axogen (AXGN) 1.7 $7.6M 936k 8.07
Biohaven (BHVN) 1.5 $6.5M 119k 54.69
2seventy Bio Common Stock (TSVT) 1.5 $6.4M 1.2M 5.35
Edgewise Therapeutics (EWTX) 1.3 $5.6M 306k 18.24
Alector (ALEC) 1.3 $5.5M 913k 6.02
Century Therapeutics (IPSC) 1.2 $5.5M 1.3M 4.18
Larimar Therapeutics (LRMR) 1.1 $5.0M 656k 7.59
Ascendis Pharma A/s Note 2.250% 4/0 (Principal) 1.0 $4.6M 4.0M 1.15
Keros Therapeutics (KROS) 1.0 $4.5M 68k 66.20
Arcus Biosciences Incorporated (RCUS) 1.0 $4.4M 232k 18.88
Galapagos Nv Spon Adr (GLPG) 1.0 $4.2M 130k 32.20
IsoRay 0.8 $3.7M 3.1M 1.19
BioCryst Pharmaceuticals (BCRX) 0.8 $3.6M 710k 5.08
Astria Therapeutics (ATXS) 0.7 $3.1M 223k 14.07
Regulus Therapeutics (RGLS) 0.7 $3.1M 1.1M 2.88
Bicycle Therapeutics Sponsored Ads (BCYC) 0.7 $3.0M 122k 24.90
Accuray Incorporated (ARAY) 0.7 $3.0M 1.2M 2.47
Insulet Corporation (PODD) 0.6 $2.7M 16k 171.40
Procept Biorobotics Corp (PRCT) 0.6 $2.7M 55k 49.42
Mediwound Shs New (MDWD) 0.6 $2.7M 189k 14.25
Silverback Therapeutics (SPRY) 0.6 $2.4M 239k 10.22
Aquestive Therapeutics (AQST) 0.5 $2.1M 500k 4.26
Proqr Therapeutics N V Shs Euro (PRQR) 0.5 $2.1M 906k 2.29
Compass Pathways Sponsored Ads (CMPS) 0.5 $2.0M 243k 8.32
Lineage Cell Therapeutics In (LCTX) 0.5 $2.0M 1.4M 1.48
Stoke Therapeutics (STOK) 0.4 $2.0M 145k 13.50
Sutro Biopharma (STRO) 0.4 $1.9M 334k 5.65
Inogen (INGN) 0.4 $1.7M 209k 8.07
Gossamer Bio (GOSS) 0.4 $1.7M 1.4M 1.18
Brainsway Sponsored Ads (BWAY) 0.4 $1.6M 298k 5.29
Biontech Se Sponsored Ads (BNTX) 0.4 $1.6M 17k 92.25
Immatics Nv SHS (IMTX) 0.3 $1.5M 145k 10.51
Neuronetics (STIM) 0.3 $1.5M 314k 4.76
Adicet Bio (ACET) 0.3 $1.4M 600k 2.35
Autolus Therapeutics Spon Ads (AUTL) 0.3 $1.4M 217k 6.38
Acelyrin (SLRN) 0.3 $1.4M 203k 6.75
Iteos Therapeutics (ITOS) 0.3 $1.3M 99k 13.64
Mineralys Therapeutics (MLYS) 0.3 $1.2M 90k 12.91
Compugen Ord (CGEN) 0.3 $1.1M 430k 2.58
Immunovant (IMVT) 0.2 $950k 29k 32.31
Acrivon Therapeutics Common Stock (ACRV) 0.2 $939k 131k 7.15
Aprea Therapeutics Com New (APRE) 0.2 $918k 137k 6.69
Polypid (PYPD) 0.2 $853k 185k 4.60
Syros Pharmaceuticals Com New (SYRS) 0.2 $727k 136k 5.35
Adaptimmune Therapeutics Sponds Adr (ADAP) 0.1 $539k 341k 1.58
Masimo Corporation (MASI) 0.1 $441k 3.0k 146.85
Nevro (NVRO) 0.1 $404k 28k 14.44
Karyopharm Therapeutics (KPTI) 0.1 $291k 193k 1.51
Vigil Neuroscience (VIGL) 0.1 $245k 72k 3.41
Compass Therapeutics (CMPX) 0.1 $231k 117k 1.98
Spero Therapeutics (SPRO) 0.0 $215k 125k 1.72
Alto Neuroscience Com Shs (ANRO) 0.0 $154k 10k 15.35